Biocon has enclosed the press release titled ‘Biocon Biologics Secures Strong Market Access Coverage for Yesintek in the United States Covering 100+ Million Lives’. The above information will also be available on the website of the Company at www.biocon.com.
The above information is a part of company’s filings submitted to BSE.